Feher MD, Richmond W. Lipids and lipid disorders. London: Gower
Medical Publishing, 1991.
Hansson GK. Mechanisms of disease: inflammation, atherosclerosis,
and coronary artery disease. New England Journal of Medicine2005;
352 : 1685–95.
Kosoglou T, Statkevich P, Johnson-Levonas AO et al. Ezetimibe – A
review of its metabolism, pharmacokinetics and drug interactions.
Clinical Pharmacokinetics2005; 44 : 467–94.
Ross R. Atherosclerosis – an inflammatory disease. New England
Journal of Medicine1999; 340 : 115–26.
Scandinavian Simvastatin Survival Study Group. Randomised trial of
cholesterol lowering in 4444 patients with coronary heart disease:
the Scandinavian Simvastatin Survival Study (4S). Lancet1994;
344 : 1383–9.
Shepherd J, Cobbe SM, Ford I et al. Prevention of coronary heart
disease with pravastatin in men with hypercholesterolemia.
New England Journal of Medicine1995; 333 : 1301–7.184 PREVENTION OF ATHEROMA:LOWERING PLASMA CHOLESTEROL AND OTHER APPROACHES